GlobalData on MSN2d
Tumour-on-chip model could help discover pancreatic cancer therapiesA team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...
Through this study, we aim to offer a new, innovative treatment to patients,” medical oncologist Dr. John Lenehan said.
TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer – – Investigational New Drug (IND) application for ...
ImmunityBio shares advanced 17% to $3.34 after the company said the Food and Drug Administration awarded a regenerative medicine advanced therapy designation for Anktiva and CAR-NK for the reversal of ...
Stockhead on MSN12d
Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 millionSeveral ASX-listed healthcare companies with low market caps are making strides in tackling cancer, a leading cause of death ...
Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...
Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...
“Thousands of people affected by pancreatic cancer rely on taking Pert tablets every time they eat simply to digest their food and absorb nutrients – something most of us take for granted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback